BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han J, Zhong J, Wei W, Wang Y, Huang Y, Yang P, Purohit S, Dong Z, Wang MH, She JX. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes. 2008;57:2118-2127. [PMID: 18477810 DOI: 10.2337/db07-1499] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Zhang L, Zhang S, Yu Q, Xiong F, Huang K, Wang C, Yang P. HMGB1, an innate alarmin, plays a critical role in chronic inflammation of adipose tissue in obesity. Molecular and Cellular Endocrinology 2017;454:103-11. [DOI: 10.1016/j.mce.2017.06.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
2 Leung SS, Forbes JM, Borg DJ. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis. Curr Diab Rep 2016;16. [DOI: 10.1007/s11892-016-0782-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
3 Zhang M, Guo Y, Fu H, Hu S, Pan J, Wang Y, Cheng J, Song J, Yu Q, Zhang S, Xu JF, Pei G, Xiang X, Yang P, Wang CY. Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFκB/IL-1β signaling. Cell Death Dis 2015;6:e1847. [PMID: 26247732 DOI: 10.1038/cddis.2015.206] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
4 Badal D, Dayal D, Singh G, Sachdeva N. Role of DNA-LL37 complexes in the activation of plasmacytoid dendritic cells and monocytes in subjects with type 1 diabetes.Sci Rep. 2020;10:8896. [PMID: 32483133 DOI: 10.1038/s41598-020-65851-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Guo T, Cai J, Peng Y, Zhang L, Lan Q, Chen Y, Liao H, Xie T, Wu P, Pan Q. Protective Effect of an Antibody against Specific Extracellular Domain of TLR2 on Agonists-Driven Inflammatory and Allergic Response. Biomed Res Int 2016;2016:9803846. [PMID: 27213155 DOI: 10.1155/2016/9803846] [Reference Citation Analysis]
6 Ran L, Yu Q, Zhang S, Xiong F, Cheng J, Yang P, Xu JF, Nie H, Zhong Q, Yang X, Yang F, Gong Q, Kuczma M, Kraj P, Gu W, Ren BX, Wang CY. Cx3cr1 deficiency in mice attenuates hepatic granuloma formation during acute schistosomiasis by enhancing the M2-type polarization of macrophages. Dis Model Mech 2015;8:691-700. [PMID: 26035381 DOI: 10.1242/dmm.018242] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
7 Tamura Y, Chiba Y, Tanioka T, Shimizu N, Shinozaki S, Yamada M, Kaneki K, Mori S, Araki A, Ito H. NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells. FEBS Lett. 2011;585:3058-3064. [PMID: 21888904 DOI: 10.1016/j.febslet.2011.08.028] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mudaliar H, Pollock C, Komala MG, Chadban S, Wu H, Panchapakesan U. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 2013;305:F143-54. [PMID: 23576640 DOI: 10.1152/ajprenal.00398.2012] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 9.2] [Reference Citation Analysis]
9 Boteanu RM, Uyy E, Suica VI, Antohe F. High-mobility group box 1 enhances the inflammatory process in diabetic lung. Arch Biochem Biophys. 2015;583:55-64. [PMID: 26254814 DOI: 10.1016/j.abb.2015.07.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
10 Pahwa R, Jialal I. The role of the high-mobility group box1 protein-Toll like receptor pathway in diabetic vascular disease. J Diabetes Complications 2016;30:1186-91. [PMID: 27037040 DOI: 10.1016/j.jdiacomp.2016.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
11 Watanabe M, Yamashita K, Kamachi H, Kuraya D, Koshizuka Y, Shibasaki S, Asahi Y, Ono H, Emoto S, Ogura M. Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance. Transplantation. 2013;96:454-462. [PMID: 23860082 DOI: 10.1097/tp.0b013e31829b077f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
12 Robinson AP, Caldis MW, Harp CT, Goings GE, Miller SD. High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis. J Autoimmun 2013;43:32-43. [PMID: 23514872 DOI: 10.1016/j.jaut.2013.02.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
13 Zhou M, Fang H, Du M, Li C, Tang R, Liu H, Gao Z, Ji Z, Ke B, Chen XL. The Modulation of Regulatory T Cells via HMGB1/PTEN/β-Catenin Axis in LPS Induced Acute Lung Injury. Front Immunol 2019;10:1612. [PMID: 31402909 DOI: 10.3389/fimmu.2019.01612] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
14 Vourc'h M, Roquilly A, Asehnoune K. Trauma-Induced Damage-Associated Molecular Patterns-Mediated Remote Organ Injury and Immunosuppression in the Acutely Ill Patient. Front Immunol 2018;9:1330. [PMID: 29963048 DOI: 10.3389/fimmu.2018.01330] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
15 Li R, Zhang J, Pan S, Yuan Y, Qi H, Shu H, Hu Y, Ren L, Jiang Y, Yuan S. HMGB1 aggravates lipopolysaccharide-induced acute lung injury through suppressing the activity and function of Tregs. Cell Immunol 2020;356:104192. [PMID: 32853967 DOI: 10.1016/j.cellimm.2020.104192] [Reference Citation Analysis]
16 Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, Nogueira-Machado JA. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis 2018;9:119. [PMID: 29371661 DOI: 10.1038/s41419-017-0135-z] [Cited by in Crossref: 309] [Cited by in F6Publishing: 290] [Article Influence: 77.3] [Reference Citation Analysis]
17 Xia Q, Duan L, Shi L, Zheng F, Gong F, Fang M. High-mobility group box 1 accelerates early acute allograft rejection via enhancing IL-17+ γδ T-cell response. Transpl Int 2014;27:399-407. [PMID: 24410759 DOI: 10.1111/tri.12264] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
18 Behl T, Sharma E, Sehgal A, Kaur I, Kumar A, Arora R, Pal G, Kakkar M, Kumar R, Bungau S. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs. Mol Biol Rep 2021;48:1869-81. [PMID: 33479829 DOI: 10.1007/s11033-020-06130-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ye X, Chopp M, Liu X, Zacharek A, Cui X, Yan T, Roberts C, Chen J. Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats. Neuroscience 2011;190:339-45. [PMID: 21683770 DOI: 10.1016/j.neuroscience.2011.06.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.6] [Reference Citation Analysis]
20 Im KI, Kim N, Lim JY, Nam YS, Lee ES, Kim EJ, Kim HJ, Kim SH, Cho SG. The Free Radical Scavenger NecroX-7 Attenuates Acute Graft-versus-Host Disease via Reciprocal Regulation of Th1/Regulatory T Cells and Inhibition of HMGB1 Release. J Immunol. 2015;194:5223-5232. [PMID: 25911749 DOI: 10.4049/jimmunol.1402609] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
21 Park HS, Kim EN, Kim MY, Lim JH, Kim HW, Park CW, Yang CW, Jin DC, Choi BS. The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in mice. Transpl Immunol 2016;34:42-9. [PMID: 26603313 DOI: 10.1016/j.trim.2015.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
22 Wang F, Sun F, Luo J, Yue T, Chen L, Zhou H, Zhang J, Yang C, Luo X, Zhou Q, Zhu H, Li J, Yang P, Xiong F, Yu Q, Zhang H, Zhang W, Xu A, Zhou Z, Lu Q, Eizirik DL, Zhang S, Wang CY. Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization. Cell Death Dis 2019;10:892. [PMID: 31767832 DOI: 10.1038/s41419-019-2130-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
23 Salpietro C, Cuppari C, Grasso L, Tosca MA, Miraglia Del Giudice M, La Rosa M, Marseglia GL, Salpietro A, Ciprandi G. Nasal high-mobility group box-1 protein in children with allergic rhinitis. Int Arch Allergy Immunol 2013;161:116-21. [PMID: 23343652 DOI: 10.1159/000345246] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
24 Kaplan HJ, Sun D, Shao H. Damage-associated Molecular Patterns in Clinical and Animal Models of Uveitis. Ocul Immunol Inflamm 2021;:1-7. [PMID: 34477485 DOI: 10.1080/09273948.2021.1954203] [Reference Citation Analysis]
25 Fujimoto K, Polonsky KS. Pdx1 and other factors that regulate pancreatic beta-cell survival. Diabetes Obes Metab 2009;11 Suppl 4:30-7. [PMID: 19817786 DOI: 10.1111/j.1463-1326.2009.01121.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 119] [Article Influence: 10.5] [Reference Citation Analysis]
26 Vives-Pi M, Rodríguez-Fernández S, Pujol-Autonell I. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review. Apoptosis 2015;20:263-72. [PMID: 25604067 DOI: 10.1007/s10495-015-1090-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
27 Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D. HMGB1 in health and disease. Mol Aspects Med 2014;40:1-116. [PMID: 25010388 DOI: 10.1016/j.mam.2014.05.001] [Cited by in Crossref: 445] [Cited by in F6Publishing: 443] [Article Influence: 55.6] [Reference Citation Analysis]
28 Zhong J, Rao X, Xu JF, Yang P, Wang CY. The role of endoplasmic reticulum stress in autoimmune-mediated beta-cell destruction in type 1 diabetes. Exp Diabetes Res 2012;2012:238980. [PMID: 22454627 DOI: 10.1155/2012/238980] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
29 Zou H, Yang Y, Gao M, Zhang B, Ming B, Sun Y, Chen H, Tang X, Chen Z, Xiong P, Xu Y, Fang M, Tan Z, Gong F, Zheng F. HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs. Am J Transplant 2014;14:1765-77. [PMID: 24984831 DOI: 10.1111/ajt.12781] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
30 Ouyang Y, Guo J, Lin C, Lin J, Cao Y, Zhang Y, Wu Y, Chen S, Wang J, Chen L, Friedman SL. Transcriptomic analysis of the effects of Toll-like receptor 4 and its ligands on the gene expression network of hepatic stellate cells. Fibrogenesis Tissue Repair 2016;9:2. [PMID: 26900402 DOI: 10.1186/s13069-016-0039-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
31 Marjanac I, Lovrić R, Barbić J. Serum levels of the high-mobility group box 1 protein (HMGB1) in children with type 1 diabetes mellitus: case-control study. Cent Eur J Immunol 2019;44:33-7. [PMID: 31114434 DOI: 10.5114/ceji.2019.84012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Wild CA, Bergmann C, Fritz G, Schuler P, Hoffmann TK, Lotfi R, Westendorf A, Brandau S, Lang S. HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells. International Immunology 2012;24:485-94. [DOI: 10.1093/intimm/dxs051] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
33 Gong Q, Zhang H, Li J, Duan L, Zhong S, Kong X, Zheng F, Tan Z, Xiong P, Chen G, Fang M, Gong F. High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice. J Mol Med 2010;88:1289-98. [DOI: 10.1007/s00109-010-0681-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
34 Li C, Peng S, Liu X, Han C, Wang X, Jin T, Liu S, Wang W, Xie X, He X, Zhang H, Shan L, Fan C, Shan Z, Teng W. Glycyrrhizin, a Direct HMGB1 Antagonist, Ameliorates Inflammatory Infiltration in a Model of Autoimmune Thyroiditis via Inhibition of TLR2-HMGB1 Signaling. Thyroid 2017;27:722-31. [PMID: 28363255 DOI: 10.1089/thy.2016.0432] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
35 Tsung A, Tohme S, Billiar TR. High-mobility group box-1 in sterile inflammation. J Intern Med. 2014;276:425-443. [PMID: 24935761 DOI: 10.1111/joim.12276] [Cited by in Crossref: 134] [Cited by in F6Publishing: 130] [Article Influence: 16.8] [Reference Citation Analysis]
36 Wang K, Tsai C, Lee C, Chen S, Chin L, Chen S. Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica. Neuroscience 2012;226:510-6. [DOI: 10.1016/j.neuroscience.2012.08.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
37 Nogueira-machado JA, Volpe CMDO, Veloso CA, Chaves MM. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opinion on Therapeutic Targets 2011;15:1023-35. [DOI: 10.1517/14728222.2011.575360] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 9.9] [Reference Citation Analysis]
38 Dong H, Li J, Lv Y, Zhou Y, Wang G, Hu S, He X, Yang P, Zhou Z, Xiang X, Wang CY. Comparative analysis of the alveolar macrophage proteome in ALI/ARDS patients between the exudative phase and recovery phase. BMC Immunol 2013;14:25. [PMID: 23773529 DOI: 10.1186/1471-2172-14-25] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
39 Kanellakis P, Agrotis A, Kyaw TS, Koulis C, Ahrens I, Mori S, Takahashi HK, Liu K, Peter K, Nishibori M, Bobik A. High-Mobility Group Box Protein 1 Neutralization Reduces Development of Diet-Induced Atherosclerosis in Apolipoprotein E–Deficient Mice. ATVB 2011;31:313-9. [DOI: 10.1161/atvbaha.110.218669] [Cited by in Crossref: 96] [Cited by in F6Publishing: 53] [Article Influence: 8.7] [Reference Citation Analysis]
40 Stoecklein VM, Osuka A, Lederer JA. Trauma equals danger--damage control by the immune system. J Leukoc Biol 2012;92:539-51. [PMID: 22654121 DOI: 10.1189/jlb.0212072] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 8.7] [Reference Citation Analysis]
41 Qi Nan W, Ling Z, Bing C. The influence of the telomere-telomerase system on diabetes mellitus and its vascular complications. Expert Opin Ther Targets 2015;19:849-64. [PMID: 25677239 DOI: 10.1517/14728222.2015.1016500] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
42 Qin WD, Mi SH, Li C, Wang GX, Zhang JN, Wang H, Zhang F, Ma Y, Wu DW, Zhang M. Low shear stress induced HMGB1 translocation and release via PECAM-1/PARP-1 pathway to induce inflammation response. PLoS One 2015;10:e0120586. [PMID: 25793984 DOI: 10.1371/journal.pone.0120586] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
43 Yang P, Zhang Y, Pang J, Zhang S, Yu Q, He L, Wagner KU, Zhou Z, Wang CY. Loss of Jak2 impairs endothelial function by attenuating Raf-1/MEK1/Sp-1 signaling along with altered eNOS activities. Am J Pathol 2013;183:617-25. [PMID: 23747947 DOI: 10.1016/j.ajpath.2013.04.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
44 Zhang S, Lv JW, Yang P, Yu Q, Pang J, Wang Z, Guo H, Liu S, Hu J, Li J, Leng J, Huang Y, Ye Z, Wang CY. Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling. Am J Pathol 2012;181:937-46. [PMID: 22796409 DOI: 10.1016/j.ajpath.2012.05.035] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
45 Jiang G, Sun D, Yang H, Lu Q, Kaplan HJ, Shao H. HMGB1 is an early and critical mediator in an animal model of uveitis induced by IRBP-specific T cells. J Leukoc Biol 2014;95:599-607. [PMID: 24374967 DOI: 10.1189/jlb.0613337] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
46 Gallo PM, Gallucci S. The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity. Front Immunol. 2013;4:138. [PMID: 23772226 DOI: 10.3389/fimmu.2013.00138] [Cited by in Crossref: 103] [Cited by in F6Publishing: 85] [Article Influence: 11.4] [Reference Citation Analysis]
47 Li M, Song L, Gao X, Chang W, Qin X. Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes. Exp Mol Med 2012;44:260-7. [PMID: 22217446 DOI: 10.3858/emm.2012.44.4.021] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
48 He X, Lai Q, Chen C, Li N, Sun F, Huang W, Zhang S, Yu Q, Yang P, Xiong F, Chen Z, Gong Q, Ren B, Weng J, Eizirik DL, Zhou Z, Wang CY. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function. Diabetologia 2018;61:881-95. [PMID: 29299635 DOI: 10.1007/s00125-017-4523-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
49 Traisaeng S, Batsukh A, Chuang TH, Herr DR, Huang YF, Chimeddorj B, Huang CM. Leuconostoc mesenteroides fermentation produces butyric acid and mediates Ffar2 to regulate blood glucose and insulin in type 1 diabetic mice. Sci Rep 2020;10:7928. [PMID: 32404878 DOI: 10.1038/s41598-020-64916-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
50 Zhong J, Yu Q, Yang P, Rao X, He L, Fang J, Tu Y, Zhang Z, Lai Q, Zhang S, Kuczma M, Kraj P, Xu J, Gong F, Zhou J, Wen L, Eizirik DL, Du J, Wang W, Wang C. MBD2 regulates TH17 differentiation and experimental autoimmune encephalomyelitis by controlling the homeostasis of T-bet/Hlx axis. Journal of Autoimmunity 2014;53:95-104. [DOI: 10.1016/j.jaut.2014.05.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
51 Forbes JM, Söderlund J, Yap FYT, Knip M, Andrikopoulos S, Ilonen J, Simell O, Veijola R, Sourris KC, Coughlan MT, Forsblom C, Slattery R, Grey ST, Wessman M, Yamamoto H, Bierhaus A, Cooper ME, Groop P. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia 2011;54:1032-42. [DOI: 10.1007/s00125-011-2058-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
52 Hamilton-Williams EE, Bergot AS, Reeves PL, Steptoe RJ. Maintenance of peripheral tolerance to islet antigens. J Autoimmun 2016;72:118-25. [PMID: 27255733 DOI: 10.1016/j.jaut.2016.05.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
53 Wang Y, Zhong J, Zhang X, Liu Z, Yang Y, Gong Q, Ren B. The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes. J Diabetes Res 2016;2016:2543268. [PMID: 28101517 DOI: 10.1155/2016/2543268] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
54 Wei W, Yang P, Pang J, Zhang S, Wang Y, Wang M, Dong Z, She J, Wang C. A stress-dependent SUMO4 sumoylation of its substrate proteins. Biochemical and Biophysical Research Communications 2008;375:454-9. [DOI: 10.1016/j.bbrc.2008.08.028] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
55 Zhong J, Yang P, Muta K, Dong R, Marrero M, Gong F, Wang CY. Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock. PLoS One 2010;5:e9593. [PMID: 20231889 DOI: 10.1371/journal.pone.0009593] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
56 Ma Y, Adjemian S, Mattarollo S, Yamazaki T, Aymeric L, Yang H, Portela catani J, Hannani D, Duret H, Steegh K, Martins I, Schlemmer F, Michaud M, Kepp O, Sukkurwala A, Menger L, Vacchelli E, Droin N, Galluzzi L, Krzysiek R, Gordon S, Taylor P, Van endert P, Solary E, Smyth M, Zitvogel L, Kroemer G. Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells. Immunity 2013;38:729-41. [DOI: 10.1016/j.immuni.2013.03.003] [Cited by in Crossref: 399] [Cited by in F6Publishing: 374] [Article Influence: 44.3] [Reference Citation Analysis]
57 Chen M, Huang W, Wang C, Nie H, Li G, Sun T, Yang F, Zhang Y, Shu K, Wang C, Gong Q. High-mobility group box 1 exacerbates CCl4-induced acute liver injury in mice. Clinical Immunology 2014;153:56-63. [DOI: 10.1016/j.clim.2014.03.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
58 Duan L, Wang CY, Chen J, Gong Q, Zhu P, Zheng F, Tan Z, Gong F, Fang M. High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response. Lab Invest. 2011;91:43-53. [PMID: 20714327 DOI: 10.1038/labinvest.2010.141] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
59 Bettini M, Vignali DA. T cell-driven initiation and propagation of autoimmune diabetes. Curr Opin Immunol 2011;23:754-60. [PMID: 22056379 DOI: 10.1016/j.coi.2011.10.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
60 Biswas SK, Mohtarin S, Mudi SR, Anwar T, Banu LA, Alam SM, Fariduddin M, Arslan MI. Relationship of Soluble RAGE with Insulin Resistance and Beta Cell Function during Development of Type 2 Diabetes Mellitus. J Diabetes Res 2015;2015:150325. [PMID: 26078977 DOI: 10.1155/2015/150325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
61 Ge WS, Wu JX, Fan JG, Wang YJ, Chen YW. Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells. World J Gastroenterol 2011; 17(36): 4090-4098 [PMID: 22039322 DOI: 10.3748/wjg.v17.i36.4090] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
62 Li J, Gong Q, Zhong S, Wang L, Guo H, Xiang Y, Ichim TE, Wang CY, Chen S, Gong F. Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol Dial Transplant. 2011;26:469-478. [PMID: 20679140 DOI: 10.1093/ndt/gfq466] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 5.4] [Reference Citation Analysis]
63 Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol 2013;13:566-77. [PMID: 23827956 DOI: 10.1038/nri3477] [Cited by in Crossref: 285] [Cited by in F6Publishing: 275] [Article Influence: 31.7] [Reference Citation Analysis]
64 Han R, Liu Z, Sun N, Liu S, Li L, Shen Y, Xiu J, Xu Q. BDNF Alleviates Neuroinflammation in the Hippocampus of Type 1 Diabetic Mice via Blocking the Aberrant HMGB1/RAGE/NF-κB Pathway. Aging Dis 2019;10:611-25. [PMID: 31165005 DOI: 10.14336/AD.2018.0707] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 8.3] [Reference Citation Analysis]
65 Maugeri N, Rovere-Querini P, Manfredi AA. Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases. Front Immunol 2016;7:182. [PMID: 27242789 DOI: 10.3389/fimmu.2016.00182] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
66 Ganguly D. Do Type I Interferons Link Systemic Autoimmunities and Metabolic Syndrome in a Pathogenetic Continuum? Trends Immunol. 2018;39:28-43. [PMID: 28826817 DOI: 10.1016/j.it.2017.07.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
67 Guo Y, Xiao Z, Wang Y, Yao W, Liao S, Yu B, Zhang J, Zhang Y, Zheng B, Ren B, Gong Q. Sodium Butyrate Ameliorates Streptozotocin-Induced Type 1 Diabetes in Mice by Inhibiting the HMGB1 Expression. Front Endocrinol (Lausanne) 2018;9:630. [PMID: 30410469 DOI: 10.3389/fendo.2018.00630] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
68 Zhang J, Chen L, Wang F, Zou Y, Li J, Luo J, Khan F, Sun F, Li Y, Liu J, Chen Z, Zhang S, Xiong F, Yu Q, Li J, Huang K, Adam BL, Zhou Z, Eizirik DL, Yang P, Wang CY. Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability. Diabetologia 2020;63:987-1001. [PMID: 32072192 DOI: 10.1007/s00125-020-05105-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
69 Boteanu RM, Suica VI, Uyy E, Ivan L, Dima SO, Popescu I, Simionescu M, Antohe F. Alarmins in chronic noncommunicable diseases: Atherosclerosis, diabetes and cancer. Journal of Proteomics 2017;153:21-9. [DOI: 10.1016/j.jprot.2016.11.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]